ARCHIVES

NCI Formaldehyde Finding Criticized

This article is from The Cancer Letter archive.

Vol. 12 No. 10 | March 7, 1986

Download PDF Visit The Full Archive

Related Articles

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

More RFPs Coming On X-Ray imaging For Early Diagnosis, Including Sound

August 23, 1974

Elderly and Younger Patients Have Similar Outcomes Following Radioembolization

July 26, 2013

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

Hugh Creech, Fox Chase Chemotherapy Pioneer, Dead at 92

January 31, 2003

Deluge Of SBIR Contract Proposals Changes Picture at NCI, Could Save $5 Million For Cancer

April 12, 1985